Yumanity Therapeutics, Inc. announced the appointment of Michael D. Wyzga as Chief Financial Officer. Mr. Wyzga has more than a decade of experience in healthcare finance. He joins the Company after eight years at Needham &Company, where he served as Vice President in the Healthcare Investment Banking group. While at Needham, Mr. Wyzga provided strategic and financial advice to clients across the life sciences sector and executed numerous initial public offerings, follow-on offerings, private placements, M&A and other transactions. Prior to this role, Mr. Wyzga was part of the Healthcare Corporate and Investment Banking group at Citigroup.